Number of items: 5.
Collapse authors list.
Griffiths, Gareth O, FitzGerald, Richard, Jaki, Thomas, Corkhill, Andrea, Reynolds, Helen ORCID: 0000-0001-7443-4520, Ewings, Sean, Condie, Susannah, Tilt, Emma, Johnson, Lucy, Radford, Mike et al (show 27 more authors) , Simpson, Catherine, Saunders, Geoffrey, Yeats, Sara, Mozgunov, Pavel, Tansley-Hancock, Olana, Martin, Karen, Downs, Nichola, Eberhart, Izabela, Martin, Jonathan WB, Goncalves, Cristiana, Song, Anna, Fletcher, Tom, Byrne, Kelly, Lalloo, David G ORCID: 0000-0001-7680-2200, Owen, Andrew ORCID: 0000-0002-9819-7651, Jacobs, Michael, Walker, Lauren ORCID: 0000-0002-3827-4387, Lyon, Rebecca, Woods, Christie, Gibney, Jennifer, Chiong, Justin ORCID: 0000-0001-8063-6399, Chandiwana, Nomathemba, Jacob, Shevin, Lamorde, Mohammed, Orrell, Catherine, Pirmohamed, Munir ORCID: 0000-0002-7534-7266 and Khoo, Saye ORCID: 0000-0002-2769-0967
(2021)
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter.
TRIALS, 22 (1).
487-.
Serra, Alessandra, Mozgunov, Pavel, Davies, Geraint ORCID: 0000-0002-3819-490X and Jaki, Thomas
(2023)
Determining the minimum duration of treatment in tuberculosis: An order restricted non-inferiority trial design.
PHARMACEUTICAL STATISTICS, 22 (5).
pp. 938-962.
Collapse authors list.
Khoo, Saye H ORCID: 0000-0002-2769-0967, FitzGerald, Richard, Saunders, Geoffrey, Middleton, Calley, Ahmad, Shazaad, Edwards, Christopher J, Hadjiyiannakis, Dennis, Walker, Lauren ORCID: 0000-0002-3827-4387, Lyon, Rebecca, Shaw, Victoria ORCID: 0000-0002-0429-0186 et al (show 80 more authors) , Mozgunov, Pavel, Periselneris, Jimstan, Woods, Christie, Bullock, Katie ORCID: 0000-0002-5758-0179, Hale, Colin, Reynolds, Helen ORCID: 0000-0001-7443-4520, Downs, Nichola, Ewings, Sean, Buadi, Amanda, Cameron, David, Edwards, Thomas, Knox, Emma, Donovan-Banfield, I'ah ORCID: 0000-0002-5124-2427, Greenhalf, William ORCID: 0000-0002-1865-3195, Chiong, Justin ORCID: 0000-0001-8063-6399, Lavelle-Langham, Lara, Jacobs, Michael, Northey, Josh, Painter, Wendy, Holman, Wayne, Lalloo, David G ORCID: 0000-0001-7680-2200, Tetlow, Michelle, Hiscox, Julian A ORCID: 0000-0002-6582-0275, Jaki, Thomas, Fletcher, Thomas, Griffiths, Gareth, Paton, Nicholas, Hayden, Fred, Darbyshire, Janet, Lucas, Amy, Lorch, Ulrika, Freedman, Andrew, Knight, Richard, Julious, Stevan, Byrne, Rachel, Cubas Atienzar, Ana, Jones, Jayne, Williams, Chris, Song, Anna, Dixon, Jan, Alexandersson, Anja, Hatchard, Parys, Tilt, Emma, Titman, Andrew, Doce Carracedo, Ale ORCID: 0009-0000-1502-0184, Chandran Gorner, Vatsi, Davies, Andrea, Woodhouse, Louis, Carlucci, Nicola, Okenyi, Emmanuel, Bula, Marcin, Dodd, Kate, Gibney, Jennifer, Dry, Lesley, Rashid Gardner, Zalina, Sammour, Amin, Cole, Christine, Rowland, Tim, Tsakiroglu, Maria, Yip, Vincent, Osanlou, Rostam, Stewart, Anna, Parker, Ben, Turgut, Tolga, Ahmed, Afshan, Starkey, Kay, Subin, Sujamole, Stockdale, Jennifer, Herring, Lisa, Baker, Jonathon, Oliver, Abigail, Pacurar, Mihaela, Owens, Dan, Munro, Alistair, Babbage, Gavin, Faust, Saul, Harvey, Matthew, Pratt, Danny, Nagra, Deepak and Vyas, Aashish
(2022)
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.
The Lancet Infectious Diseases, 23 (2).
pp. 183-195.
Collapse authors list.
Walker, Lauren E ORCID: 0000-0002-3827-4387, FitzGerald, Richard, Saunders, Geoffrey, Lyon, Rebecca, Fisher, Michael, Martin, Karen, Eberhart, Izabela, Woods, Christie, Ewings, Sean, Hale, Colin et al (show 23 more authors) , Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Else, Laura, Dilly-Penchala, Sujan, Amara, Alieu ORCID: 0000-0002-1137-2948, Lalloo, David G ORCID: 0000-0001-7680-2200, Jacobs, Michael, Pertinez, Henry, Hatchard, Parys, Waugh, Robert, Lawrence, Megan, Johnson, Lucy, Fines, Keira, Reynolds, Helen ORCID: 0000-0001-7443-4520, Rowland, Timothy, Crook, Rebecca, Okenyi, Emmanuel, Byrne, Kelly, Mozgunov, Pavel, Jaki, Thomas, Khoo, Saye ORCID: 0000-0002-2769-0967, Owen, Andrew ORCID: 0000-0002-9819-7651, Griffiths, Gareth and Fletcher, Thomas E
(2022)
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 111 (3).
pp. 585-594.
Collapse authors list.
Khoo, Saye H ORCID: 0000-0002-2769-0967, Fitzgerald, Richard, Fletcher, Thomas, Ewings, Sean, Jaki, Thomas, Lyon, Rebecca, Downs, Nichola, Walker, Lauren ORCID: 0000-0002-3827-4387, Tansley-Hancock, Olana, Greenhalf, William et al (show 28 more authors) , Woods, Christie, Reynolds, Helen ORCID: 0000-0001-7443-4520, Marwood, Ellice, Mozgunov, Pavel, Adams, Emily, Bullock, Katie ORCID: 0000-0002-5758-0179, Holman, Wayne, Bula, Marcin D, Gibney, Jennifer L, Saunders, Geoffrey, Corkhill, Andrea, Hale, Colin, Thorne, Kerensa, Chiong, Justin ORCID: 0000-0001-8063-6399, Condie, Susannah, Pertinez, Henry, Painter, Wendy, Wrixon, Emma, Johnson, Lucy, Yeats, Sara, Mallard, Kim, Radford, Mike, Fines, Keira, Shaw, Victoria ORCID: 0000-0002-0429-0186, Owen, Andrew ORCID: 0000-0002-9819-7651, Lalloo, David G ORCID: 0000-0001-7680-2200, Jacobs, Michael and Griffiths, Gareth
(2021)
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (12).
pp. 3286-3295.
This list was generated on Sun Feb 11 20:14:37 2024 GMT.